News and press releases

EMA starts review of ipidacrine-containing medicines

EMA’s human medicines committee (CHMP) has started a review of medicines containing ipidacrine. These medicines have been authorised in several EU countries through national…

May 23, 2025 - 13:35
 0
EMA starts review of ipidacrine-containing medicines
EMA’s human medicines committee (CHMP) has started a review of medicines containing ipidacrine. These medicines have been authorised in several EU countries through national…
Read More

Tags:

Previous Article

Changes to the use of antibiotic azithromycin

Next Article

New treatment for adults with acute lymphoblastic leukaemia

Related Posts

Management Board meeting on possible renewal of Executive Director’s mandate

Management Board meeting on possible renewal of Executi...

May 12, 2025  0

ETF recommends updating COVID-19 vaccines to target new LP.8.1 variant

ETF recommends updating COVID-19 vaccines to target new...

May 16, 2025  0

New treatment against Duchenne muscular dystrophy

New treatment against Duchenne muscular dystrophy

May 12, 2025  0